±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 235  |  »Ø¸´: 1
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

yyat

Òø³æ (ÕýʽдÊÖ)

[½»Á÷] Ò»¶ÎÓ¢ÎÄÕªÒª·­ÒëÇóÖú ¶àл

Ibuprofen Inhibits Skeletal Muscle Hypertrophy in Rats
Abstract
Purpose: We sought to determine whether cyclooxygenase (COX) activity is necessary for overload-induced growth of adult rat skeletal muscle, and whether nitric oxide synthase (NOS) activity is involved in upregulation of COX messenger RNA (mRNA) expression in skeletal muscle.
Methods: Unilateral surgical removal of the gastrocnemius and soleus was performed on the right hindlimb of 16 female Sprague-Dawley rats (~230 g) to induce chronic overload (OL) of the plantaris for 14 d, with sham surgeries performed on the contralateral leg as a normally loaded (NL) control. Half of the rats were treated with the nonspecific COX inhibitor, ibuprofen (0.2 mg•mL-1 in drinking water; ~20 mg•kg-1•d-1). In a second experiment, the plantaris was unilaterally overloaded for 5 or 14 d in male rats (~350 g; N = 16 rats per time point) and half of the animals were treated with the NOS inhibitor, L-NAME (0.75 mg•mL-1 in drinking water; ~90 mg•kg-1•d-1).
Results: Ibuprofen treatment inhibited plantaris hypertrophy by approximately 50% (P < 0.05) following 14 d of OL, as did L-NAME treatment (P < 0.05). COX-1 and COX-2 mRNA did not differ between any groups at 5 d. At 14 d, however, L-NAME caused a 30-fold increase in plantaris COX-1 mRNA expression independent of loading condition. Additionally, OL induced a 20-fold increase in COX-2 mRNA expression compared with NL (P < 0.05) at 14 d, without affecting COX-1 mRNA level. L-NAME treatment significantly inhibited OL-induced expression of COX-2 mRNA.
Conclusion: COX activity is important for in vivo muscle hypertrophy, and plantaris overload is associated with NOS activity-dependent COX-2 expression.
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

pharmjackie

ľ³æ (ÕýʽдÊÖ)

yyat(½ð±Ò+10):лл 2010-03-30 08:29
ÊÔÒëÈçÏ£º²»ÉõÑϽ÷£¬²»ÉõÕýÈ·£¬ÇëרҵÈËʿָÕý£º
²¼Âå·ÒÔÚÊóÖÐÒÖÖÆ¹Ç÷À¼¡·Ê´ó×÷ÓÃÑо¿
ÕªÒª£ºÎÒÃÇÑо¿ÁË»·ÑõºÏø£¨COX£©µÄ»îÐÔ¶ÔÓÚ³ÉÄêÊó¹Ç÷À¼¡³¬¸ººÉÓÕµ¼µÄµÄÉú³¤ÊÇ·ñ±ØÐ룬һÑõ»¯µªºÏ³Éø(NOS)ÊÇ·ñÔÚCOXµÄmRNAÔÚ¹Ç÷À¼¡±í´ïµÄÉϵ÷Öз¢»Ó×÷Óá£
·½·¨£º¶Ô16Ö»´ÆÐÔSprague-DawleyÊó£¨Ô¼230¿Ë£©µÄÓÒºóÖ«½øÐе¥²àÊÖÊõÒÆ³ýë賦¼¡ºÍ±ÈÄ¿Ó㼡£¬ÒÔʹÄÚÓÕµ¼õż¡ÂýÐÔ³¬¸ººÉ£¨OL£©14Ì죬¶ÔÆä¶Ô²àÖ«Ìå×÷¼ÙÊÖÊõÒÔ×÷ΪÕý³£¸ººÉµÄ¶ÔÕÕ£¨NL£©¡£°ëÊýÊóʹÓ÷ÇÌØÒìÐÔCOXÒÖÖÆ¼Á£¬²¼Âå·Ò£¨ÓÚÆäÒûË®ÖмÓÈë0.2mg/ml£¬Ô¼20mg/kg.Ì죩¡£ÁíÒ»ÏîʵÑéÖУ¬Ê¹ÐÛÊóõż¡µ¥²à³¬¸ººÉ5»ò14Ì죨Լ350¿Ë£¬Ã¿Ê±¼äµãÑù±¾Êý16Ö»£©£¬ÆäÖаëÊý¶¯ÎïʹÓÃNOS,L-NAME(ÒûË®ÖмÓÈë0.75mg/ml£¬Ô¼90mg/Kg.Ìì¡£
½á¹û£º14ÌìOLºóʹÓò¼Âå·ÒÖÎÁÆõÅ·ÊÒÖÖÆÂÊ´óÔ¼50%£¨P<0.05)£¬ÓëL-NAMEÏàËÆ£¨P<0.05).Á½×éÔÚµÚ5ÌìʱµÄCOX-1ºÍCOX-2 mRNA²¢Ã»ÓÐÏÔÖø²îÒ졣Ȼ¶øÔÚµÚ14Ììʱ£¬L-NAMEÒýÆðõż¡COX-1 mRNA±í´ïÔö³¤ÁË30±¶£¬ÇÒÓ븺ºÉÎ޹ء£´ËÍ⣬ÓëNLÏà±È£¬ÔÚµÚ14ÌìʱOLÒýÆðCOX-2 mRNA±í´ïÔö³¤20±¶£¨P<0.05)£¬ÇÒûÓÐÓ°ÏìCOX-1 mRNAˮƽ¡£Ê¹ÓÃL-NAMEÖÎÁÆÏÔÖøÒÖÖÆÁËOL-ÓÕµ¼µÄCOX-2 mRNA±í´ï¡£
½áÂÛ£º COX»îÐÔÔÚÌåÄÚ¹Ç÷À¼¡·Ê´óÖÐÆð×ÅÖØÒª×÷Óá£õż¡³¬¸ººÉÊÇÓëNOS»îÐÔÒÀÀµµÄCOX-2±í´ï¹ØÏµÃÜÇС£
2Â¥2010-03-22 19:37:44
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ yyat µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Ò»Ö¾Ô¸Äϲý´óѧ324Çóµ÷¼Á +8 hanamiko 2026-03-30 8/400 2026-04-04 08:33 by leqianduo
[¿¼ÑÐ] 265Çóµ÷¼Á +17 ÁÖÉîÎÂÀ½ 2026-04-01 20/1000 2026-04-04 01:09 by userper
[¿¼ÑÐ] 320·ÖÈ˹¤ÖÇÄܵ÷¼Á +6 Õñ¡ªTZ 2026-04-03 6/300 2026-04-04 01:05 by Dream007008
[¿¼ÑÐ] 295Çóµ÷¼Á +3 ÉÐټѽ 2026-04-03 4/200 2026-04-03 21:23 by zhq0425
[¿¼ÑÐ] ÊÞÒ½µ÷¼Á +3 wh119216 2026-04-02 3/150 2026-04-03 19:34 by zrongyan
[˶²©¼ÒÔ°] ÇóÀÏʦÊÕÁô +9 lllq123 2026-04-03 9/450 2026-04-03 13:48 by ºôÎü¶¼ÊǼõ·Ê
[¿¼ÑÐ] 316Çóµ÷¼Á +14 ÖÛ×Ô¹£ 2026-04-01 18/900 2026-04-03 10:28 by linyelide
[¿¼ÑÐ] 081200-11408-276ѧ˶Çóµ÷¼Á +6 ´Þwj 2026-04-02 6/300 2026-04-03 10:19 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 289Çóµ÷¼Á +4 Acesczlo 2026-03-29 5/250 2026-04-03 10:09 by ²»168
[¿¼ÑÐ] һ־Ըɽ¶«´óѧ»¯Ñ§Ó뻯¹¤Ñ§Ôº²ÄÁÏÓ뻯¹¤×¨Ë¶£¬360·ÖÇóµ÷¼Á +4 ²»Ô¸Í¸Â¶ÐÕÃûµÄË 2026-04-02 4/200 2026-04-03 09:29 by ÒÅÍüÏûʧµÄž™
[¿¼ÑÐ] µ÷¼Á +7 ìíáº. 2026-04-02 7/350 2026-04-03 09:11 by »¨ß»¹Ç·600
[¿¼ÑÐ] Ò»Ö¾Ô¸ÄÏ¿ª´óѧ0710ÉúÎïѧ359Çóµ÷¼Á +6 ÍÃÍÃÍÃ111223314 2026-03-29 8/400 2026-04-02 22:37 by louise0220
[¿¼ÑÐ] 282Çóµ÷¼Á +3 aaa³µÁ¾ 2026-04-02 3/150 2026-04-02 21:55 by zllcz
[¿¼ÑÐ] 271Çóµ÷¼Á +15 ÀÕ²¼ÀÊ@ 2026-03-31 20/1000 2026-04-02 11:24 by Sammy2
[¿¼ÑÐ] 350Çóµ÷¼Á +7 °¢¼Ñ¡« 2026-03-31 7/350 2026-04-01 16:12 by yanflower7133
[¿¼ÑÐ] 086000ÉúÎïÓëÒ½Ò© ³õÊÔ274Çóµ÷¼Á +5 С¶£µ±À´ÁË 2026-03-30 6/300 2026-04-01 14:25 by mxj1203
[¿¼ÑÐ] 086000ÉúÎïÓëÒ½Ò©298µ÷¼ÁÇóÖú +4 ÔªÔªÇàÇà 2026-03-31 6/300 2026-04-01 11:13 by syh9288
[¿¼ÑÐ] һ־Ը˫һÁ÷»úе285·ÖÇóµ÷¼Á +4 ÐÒÔ˵ÄÈýľ 2026-03-29 5/250 2026-03-29 14:49 by Miko19
[¿¼ÑÐ] 332Çó92µ÷¼Á +8 ½¶½¶123 2026-03-28 8/400 2026-03-29 10:46 by ÖÜè÷µ¤
[¿¼ÑÐ] Çóµ÷¼Á +7 ÕùÈ¡¾Åµã˯ 2026-03-28 8/400 2026-03-28 21:07 by ÕùÈ¡¾Åµã˯
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û